Multimodal Imaging Usability in Basal Cell Carcinoma
Official title: Multimodal Imaging of Basal Cell Carcinoma: A Usability Study
Run by Bispebjerg Hospital · NCT07803406 · Data updated 2026-11-12
We’re testing how easy and quick three non-invasive imaging tools are for adults with basal cell carcinoma to use during a single visit.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 50 (estimated) |
| Sponsor | Bispebjerg Hospital Academic / other |
| Locations | 1 site (Copenhagen, Denmark) |
| Status | Recruiting |
| Started | September 14, 2026 |
| Main results expected | June 25, 2027 |
| Study ends | November 5, 2027 |
| Registry record updated | September 3, 2026 |
| Trial ID | NCT07803406 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 18 and older with a histologically confirmed or clinically suspected BCC lesion planned for standard management.
✕Probably not a fit
Patients whose lesion characteristics or anatomical location limit usefulness of one or more imaging modalities may see limited benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study assesses time efficiency and practical usability of three non-invasive skin imaging modalities—optical coherence tomography, line-field confocal optical coherence tomography, and high-frequency ultrasound—in adults with basal cell carcinoma. Each participant will undergo a single ~40-minute visit during which all three scans are performed on the lesion, followed by a short experience questionnaire. The study aims to compare scan duration, participant comfort, and performance across body areas, without any biopsies or invasive procedures. Results will help determine whether these tools can complement current diagnostic pathways and guide future implementation in clinical care.
Why it matters
Potential benefit: If successful, this approach could streamline non-invasive assessment of BCC and reduce reliance on invasive biopsy for certain diagnostic and management decisions.
How similar studies have gone: Previous non-invasive imaging studies show promise for characterizing skin lesions, but comprehensive usability data across multiple modalities remain limited.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: Age 18 years or older Presence of a histologically confirmed or clinically suspected basal cell carcinoma lesion scheduled for standard clinical management Ability to provide written informed consent Exclusion Criteria: Inability to provide informed consent
Where it's running
-
Department of Dermatology, Bispebjerg Hospital
Copenhagen, Denmark, Denmark Recruiting
Study contacts
- Principal investigator: Merete Hædersdal, Professor — Bispebjerg Hospital
- Study coordinator: Otto Dideriksen, MD
- Email: otto.dideriksen@regionh.dk
- Phone: +45 29103585
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Two-photon microscopy on skin biopsies to help diagnose skin lesions
This study tests whether images from two-photon fluorescence microscopy of dermatology biopsies can match the diagnosis determined by standard histology.
-
Machine learning assessment of two-photon microscopy images from skin biopsies
A machine learning model is tested on two-photon microscopy images of skin biopsy samples taken in clinic to see if it can correctly predict basal cell carcinoma, squamous cell carcinoma, or non-cancer compared with standard histology.
-
First-in-human test of KUP-101A in selected advanced skin cancers
This early study tests KUP-101A to see if it's safe and tolerable and to gather initial clues about its activity in patients with advanced skin cancers.
-
Real-world use of LC-OCT to help diagnose basal cell carcinoma
This study tests how well LC-OCT works in everyday dermatology practice to help diagnose basal cell carcinoma without always needing a biopsy.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.